CRISPR/Cas 9 Technology

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assembly of the next generation of bioproducts. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, biochemicals, agricultural crops, and travel applications.

  • Achieving Efficient Delivery and Editing
  • Horizons of CRISPR Biology

Related Conference of CRISPR/Cas 9 Technology

CRISPR/Cas 9 Technology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in